{"id":75515,"date":"2024-04-22T12:45:39","date_gmt":"2024-04-22T18:45:39","guid":{"rendered":"https:\/\/www.uchealth.org\/today\/?p=75515"},"modified":"2024-04-23T08:25:05","modified_gmt":"2024-04-23T14:25:05","slug":"promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines","status":"publish","type":"post","link":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/","title":{"rendered":"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines"},"content":{"rendered":"
<\/div>
\"There\u2019s
There\u2019s nothing easy about preparing for a stem cell transplant for acute myeloid leukemia (AML), Matt Lubick and others will tell you. But a clinical trial at the University of Colorado School of Medicine made a big difference for the longtime college football coach. Photo by Joel Blocker for UCHealth.<\/figcaption><\/figure>\n

By Greg Glasgow<\/strong><\/p>\n

Matt Lubick had finished marathons before, but none was so personally meaningful as the 26-mile distance he covered in one day while being treated for acute myeloid leukemia<\/a> at UCHealth University of Colorado Hospital<\/a> on the Anschutz Medical Campus<\/a>. Lubick walked dozens of laps around the facility, wheeling his IV pole up and down the corridors as day slowly turned to night outside the tall glass windows.<\/p>\n

\u201cIt was my first day of chemotherapy, and it felt really good to walk,\u201d Lubick says. \u201cMy doctors gave me a lot of hope and confidence going into this, which I didn\u2019t necessarily have before. They made me feel like, \u2018You’re not a statistic, you’re a person. You’re in really good shape, and things are going to be OK.\u2019 When someone believes in you, it gives you hope. It gives you energy.\u201d<\/p>\n

What started as a way to stretch his legs during treatment became a personal challenge for Lubick when a hospital staffer mentioned that another patient had walked the length of a marathon throughout the hospital years ago. Lubick set out to see if he could do the same.<\/p>\n

\"Lubick
Lubick at the Boston Marathon finish in April 2023, just months before his diagnosis. The former college defensive back finished in a blazing 3:01:23. His \u201cmarathon\u201d in the halls of UCHealth University of Colorado Hospital took many hours longer. Photo courtesy of Matt Lubick.<\/figcaption><\/figure>\n

It was a reflection of the kind of person Lubick is, says University of Colorado School of Medicine<\/a> blood cancer specialist Dr. Dan Pollyea<\/a>, who was part of Lubick\u2019s treatment team.<\/p>\n

\u201cThere are unhealthy coping mechanisms, and there are healthy coping mechanisms, and it\u2019s a pretty healthy coping mechanism to say, \u2018I’m in this horrible situation, but not only am I going to stay positive, I’m going to challenge myself,\u2019\u201d Pollyea says. \u201cMatt said, \u2018I’m going to do something that I love to do, I’m not going to let the limitations of being in the hospital impact me, I’m going to do what I always do, which is get up and move. I’m going to set a goal and meet it.\u2019 I’m sure that helped him adapt to his situation.\u201d<\/p>\n

Diagnosing a mystery illness<\/strong><\/h2>\n

For Lubick, 52, who recently took a new job as offensive coordinator<\/a> for the University of Nevada football program (he\u2019s the son of former Colorado State University football coach Sonny Lubick), that situation began in August 2023, while he was training for another marathon. Lingering fatigue and a series of low-grade fevers prompted Lubick to see his doctor, who at first suspected a viral infection because of low blood cell counts. Lubick, who then lived in Fort Collins, spent a few days in the hospital, but even after he was discharged, his white blood cell counts remained dangerously low.<\/p>\n

\"Dr.
Dr. Daniel Pollyea<\/figcaption><\/figure>\n

His doctors eventually ordered a bone marrow biopsy, which led to a diagnosis of acute myeloid leukemia (AML), a blood cancer<\/a> that starts in the bone marrow. He was referred to the CU Cancer Center for treatment \u2013 specifically to Pollyea, who is overseeing an active clinical trial<\/a> of a medication called venetoclax combined with a low dose of the chemotherapy drug azacitidine, for patients with AML.<\/p>\n

\u201cWe have found that this regimen is able to target the leukemia stem cell population \u2013 the root cause of the disease,\u201d Pollyea says. \u201cIf you think of leukemia like a weed, there’s the flower part, like a dandelion, that chemotherapy can come in and mow over. Maybe you don’t see it anymore, but the roots are still there. Venetoclax with low-dose chemotherapy has the potential to get at the roots of the disease, and if you can pull up the roots of the disease, you can get a long-term remission or even a cure.\u201d<\/p>\n

Remission accomplished<\/h2>\n

Lubick went into remission just two weeks after starting the treatment and was able to go home after the chemotherapy portion, while still taking the venetoclax, which is a pill patients take orally. He says he feels fortunate to have been treated by his CU Cancer Center team that included Pollyea and colleague Dr. Christine McMahon<\/a>, also a blood cancer specialist.<\/p>\n

\"Lubick
Lubick with dad Sonny and Mom Carol. Photo courtesy of Matt Lubick.<\/figcaption><\/figure>\n

\u201cIt was a real blessing that I was able to be part of that trial and to have the leadership of Dr. McMahon and Dr. Pollyea to advise me to be on it,\u201d he says. \u201cI had no experience to judge it on, but it couldn’t have been more effective. I can’t emphasize enough how well I felt while I was on it.\u201d<\/p>\n

McMahon says that for a young, fit patient like Lubick, the venetoclax-azacitidine combination allows for much more activity during treatment.<\/p>\n

\u201cIf he had gotten the traditional intensive chemotherapy, he would have had to stay in the hospital for a month,\u201d she says. \u201cWith this clinical trial regimen, he was able to go home after the first week of treatment, and he stayed extremely active throughout his treatment.\u201d<\/p>\n

On to transplant<\/h2>\n

The final step in Lubick\u2019s treatment was a stem cell transplant, which was performed in December 2023 at UCHealth University of Colorado Hospital. The haploidentical, or \u201chaplo\u201d transplant used a combination of cord blood and donated blood from Lubick\u2019s sister Michelle. CU School of Medicine stem cell transplant specialist Dr. Jonathan Gutman<\/a>\u00a0led the procedure.<\/p>\n

\"Lubick,
Lubick, now cancer free, is looking forward to his new role as the University of Nevada football team\u2019s offensive coordinator. Photo by Joel Blocker for UCHealth.<\/figcaption><\/figure>\n

Though the medication combination put him into remission, McMahon says, a stem cell transplant replaces the recipient\u2019s blood-producing bone marrow with donor cells. This not only ensured that the leukemia cells were gone from his system, but it also essentially provided him with a new immune system that can prevent the leukemia from coming back.<\/p>\n

\u201cThe venetoclax-azacitidine regimen was initially studied in the elderly population, and many of those patients are not candidates for stem cell transplant,\u201d McMahon says. \u201cThere is an option to continue venetoclax indefinitely for patients who continue to respond to treatment, and it’s possible that it might be able to cure a small proportion of patients with AML. There are reports of long-term survivors who have been able to stop this treatment without a stem cell transplant and haven\u2019t relapsed. But that’s not the majority of people. For a younger, fit patient like Matt, a transplant is the best chance for long-term cure of his leukemia.\u201d<\/p>\n

\"Dr.
Dr. Christine McMahon<\/figcaption><\/figure>\n

All told, Lubick was in the hospital for 32 days while receiving the stem cell transplant, and he had to remain within a 30-mile radius of the hospital for two months after that. Aside from an intense fever that is a common side effect of the transplant, he came through the procedure just fine, McMahon says.<\/p>\n

\u201cHe\u2019ll still need regular monitoring, with bloodwork and some occasional bone marrow biopsies, but the frequency of his visits really decreases now that he\u2019s doing well.\u201d<\/p>\n

Look on the bright side<\/h2>\n

Lubick knows that not every patient with AML comes through treatment with the same positive results he has. And while his cancer journey has had its share of struggles, it has had its bright spots as well, he says.<\/p>\n

\u201cThere are some things I\u2019m thankful for because of this,\u201d he says. \u201cMy faith has been strengthened, and I needed that to happen. My priorities have shifted \u2013 things I used to think were important, or that stressed me out, don’t stress me out and aren’t that important. I have a lot more appreciation for life. My relationships with friends and family have become stronger through this.<\/p>\n

\u201cI\u2019ve had a unique opportunity to talk to so many people because of my experience \u2013 people have reached out to help me that I didn’t know,\u201d he adds. \u201cIt’s been very humbling. I’m hoping down the line that I can help other people in the same way people are helping me right now. There\u2019s a physical part to healing, which is a big deal, but there\u2019s a mental and spiritual part of it too. Adversity is inevitable, but being miserable is optional.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

By Greg Glasgow Matt Lubick had finished marathons before, but none was so personally meaningful as the 26-mile distance he covered in one day while being treated for acute myeloid leukemia at UCHealth University of Colorado Hospital on the Anschutz Medical Campus. Lubick walked dozens of laps around the facility, wheeling his IV pole up […]<\/p>\n","protected":false},"author":22,"featured_media":75520,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[7],"tags":[28,49,167,2563],"class_list":["post-75515","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stories","tag-cancer-care-oncology","tag-cancer-treatment","tag-clinical-trials","tag-leukemia"],"acf":[],"yoast_head":"\nPromising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines - UCHealth Today<\/title>\n<meta name=\"description\" content=\"Longtime football coach, Matt Lubick, participated in a clinical trial that targets stem cells that cause AML.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines\" \/>\n<meta property=\"og:description\" content=\"Longtime football coach, Matt Lubick, participated in a clinical trial that targets stem cells that cause AML.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/\" \/>\n<meta property=\"og:site_name\" content=\"UCHealth Today\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/uchealthorg\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-22T18:45:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-23T14:25:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.jpg\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"UCHealth Writers\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uchealth\" \/>\n<meta name=\"twitter:site\" content=\"@uchealth\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"UCHealth Writers\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/\"},\"author\":{\"name\":\"UCHealth Writers\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#\/schema\/person\/b42635b22028b4761efa8849bfec3811\"},\"headline\":\"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines\",\"datePublished\":\"2024-04-22T18:45:39+00:00\",\"dateModified\":\"2024-04-23T14:25:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/\"},\"wordCount\":1492,\"publisher\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.webp\",\"keywords\":[\"Cancer care\",\"Cancer treatment\",\"Clinical trials\",\"Leukemia\"],\"articleSection\":[\"Stories\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/\",\"url\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/\",\"name\":\"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines - UCHealth Today\",\"isPartOf\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.webp\",\"datePublished\":\"2024-04-22T18:45:39+00:00\",\"dateModified\":\"2024-04-23T14:25:05+00:00\",\"description\":\"Longtime football coach, Matt Lubick, participated in a clinical trial that targets stem cells that cause AML.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#primaryimage\",\"url\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.webp\",\"contentUrl\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.webp\",\"width\":800,\"height\":533,\"caption\":\"There\u2019s nothing easy about preparing for a stem cell transplant for acute myeloid leukemia (AML), Matt Lubick and others will tell you. But a clinical trial at the University of Colorado School of Medicine made a big difference for the longtime college football coach. Photo by Joel Blocker for UCHealth.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.uchealth.org\/today\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#website\",\"url\":\"https:\/\/www.uchealth.org\/today\/\",\"name\":\"UCHealth Today\",\"description\":\"UCHealth Today\",\"publisher\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.uchealth.org\/today\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#organization\",\"name\":\"UCHealth\",\"url\":\"https:\/\/www.uchealth.org\/today\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2020\/04\/24135149\/UCHealth-square-logo-1000x1000-1.jpg\",\"contentUrl\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2020\/04\/24135149\/UCHealth-square-logo-1000x1000-1.jpg\",\"width\":1000,\"height\":1000,\"caption\":\"UCHealth\"},\"image\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/uchealthorg\/\",\"https:\/\/x.com\/uchealth\",\"https:\/\/www.instagram.com\/uchealth\/\",\"https:\/\/www.linkedin.com\/school\/14839\/\",\"https:\/\/www.pinterest.com\/uchealthorg\/\",\"https:\/\/www.youtube.com\/channel\/UC41SJI79yjZIe96OajzN22g\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#\/schema\/person\/b42635b22028b4761efa8849bfec3811\",\"name\":\"UCHealth Writers\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/7e908f81c51be4709fddf41493942c85900762f0c10e3bc19d1ee8dc5bf0f223?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7e908f81c51be4709fddf41493942c85900762f0c10e3bc19d1ee8dc5bf0f223?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7e908f81c51be4709fddf41493942c85900762f0c10e3bc19d1ee8dc5bf0f223?s=96&d=mm&r=g\",\"caption\":\"UCHealth Writers\"},\"url\":\"https:\/\/www.uchealth.org\/today\/author\/uchealthwriters\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines - UCHealth Today","description":"Longtime football coach, Matt Lubick, participated in a clinical trial that targets stem cells that cause AML.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/","og_locale":"en_US","og_type":"article","og_title":"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines","og_description":"Longtime football coach, Matt Lubick, participated in a clinical trial that targets stem cells that cause AML.","og_url":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/","og_site_name":"UCHealth Today","article_publisher":"https:\/\/www.facebook.com\/uchealthorg\/","article_published_time":"2024-04-22T18:45:39+00:00","article_modified_time":"2024-04-23T14:25:05+00:00","og_image":[{"url":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.jpg","type":"image\/jpeg"}],"author":"UCHealth Writers","twitter_card":"summary_large_image","twitter_creator":"@uchealth","twitter_site":"@uchealth","twitter_misc":{"Written by":"UCHealth Writers","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#article","isPartOf":{"@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/"},"author":{"name":"UCHealth Writers","@id":"https:\/\/www.uchealth.org\/today\/#\/schema\/person\/b42635b22028b4761efa8849bfec3811"},"headline":"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines","datePublished":"2024-04-22T18:45:39+00:00","dateModified":"2024-04-23T14:25:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/"},"wordCount":1492,"publisher":{"@id":"https:\/\/www.uchealth.org\/today\/#organization"},"image":{"@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.webp","keywords":["Cancer care","Cancer treatment","Clinical trials","Leukemia"],"articleSection":["Stories"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/","url":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/","name":"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines - UCHealth Today","isPartOf":{"@id":"https:\/\/www.uchealth.org\/today\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#primaryimage"},"image":{"@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.webp","datePublished":"2024-04-22T18:45:39+00:00","dateModified":"2024-04-23T14:25:05+00:00","description":"Longtime football coach, Matt Lubick, participated in a clinical trial that targets stem cells that cause AML.","breadcrumb":{"@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#primaryimage","url":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.webp","contentUrl":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2024\/04\/22122042\/Matt-Lubick-footballsized.webp","width":800,"height":533,"caption":"There\u2019s nothing easy about preparing for a stem cell transplant for acute myeloid leukemia (AML), Matt Lubick and others will tell you. But a clinical trial at the University of Colorado School of Medicine made a big difference for the longtime college football coach. Photo by Joel Blocker for UCHealth."},{"@type":"BreadcrumbList","@id":"https:\/\/www.uchealth.org\/today\/promising-acute-myeloid-leukemia-treatment-helps-put-matt-lubick-back-on-the-sidelines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.uchealth.org\/today\/"},{"@type":"ListItem","position":2,"name":"Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines"}]},{"@type":"WebSite","@id":"https:\/\/www.uchealth.org\/today\/#website","url":"https:\/\/www.uchealth.org\/today\/","name":"UCHealth Today","description":"UCHealth Today","publisher":{"@id":"https:\/\/www.uchealth.org\/today\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.uchealth.org\/today\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.uchealth.org\/today\/#organization","name":"UCHealth","url":"https:\/\/www.uchealth.org\/today\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.uchealth.org\/today\/#\/schema\/logo\/image\/","url":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2020\/04\/24135149\/UCHealth-square-logo-1000x1000-1.jpg","contentUrl":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2020\/04\/24135149\/UCHealth-square-logo-1000x1000-1.jpg","width":1000,"height":1000,"caption":"UCHealth"},"image":{"@id":"https:\/\/www.uchealth.org\/today\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/uchealthorg\/","https:\/\/x.com\/uchealth","https:\/\/www.instagram.com\/uchealth\/","https:\/\/www.linkedin.com\/school\/14839\/","https:\/\/www.pinterest.com\/uchealthorg\/","https:\/\/www.youtube.com\/channel\/UC41SJI79yjZIe96OajzN22g"]},{"@type":"Person","@id":"https:\/\/www.uchealth.org\/today\/#\/schema\/person\/b42635b22028b4761efa8849bfec3811","name":"UCHealth Writers","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7e908f81c51be4709fddf41493942c85900762f0c10e3bc19d1ee8dc5bf0f223?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7e908f81c51be4709fddf41493942c85900762f0c10e3bc19d1ee8dc5bf0f223?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7e908f81c51be4709fddf41493942c85900762f0c10e3bc19d1ee8dc5bf0f223?s=96&d=mm&r=g","caption":"UCHealth Writers"},"url":"https:\/\/www.uchealth.org\/today\/author\/uchealthwriters\/"}]}},"coauthors":[{"id":22,"name":"UCHealth Writers","link":"https:\/\/www.uchealth.org\/today\/author\/uchealthwriters\/"}],"_links":{"self":[{"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/posts\/75515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/comments?post=75515"}],"version-history":[{"count":10,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/posts\/75515\/revisions"}],"predecessor-version":[{"id":75546,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/posts\/75515\/revisions\/75546"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/media\/75520"}],"wp:attachment":[{"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/media?parent=75515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/categories?post=75515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/tags?post=75515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}